NSB 2.56% 4.0¢ neuroscientific biopharmaceuticals ltd

Ann: Results from Pulmonary Studies, page-39

  1. 2,038 Posts.
    lightbulb Created with Sketch. 342
    https://www.nature.com/articles/s41392-021-00679-0


    Cytokine-based interventions

    The current treatment for CS is mainly based on traditional anti-inflammatory drugs such as the administration of corticosteroids, chloroquine, and colchicines.210,211 Recently, biologics like recombinant cytokines; monoclonal antibodies against IL-6, IL-1β, TNF-α, and IFN-γ; and signaling pathway inhibitors are also available or in the pipeline for production. In this and the next section, we aim to discuss the key biologics that are currently or potentially applied to treat CS (Fig. 6).

 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $5.784M
Open High Low Value Volume
3.9¢ 4.0¢ 3.6¢ $5.263K 142.7K

Buyers (Bids)

No. Vol. Price($)
2 20181 3.6¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 125000 1
View Market Depth
Last trade - 15.40pm 28/06/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.